Mustang Bio, Inc. posts annual revenue of $689,000 in 2022

Mustang Bio, Inc. [MBIO] has reported $77.52 million loss for the fiscal year ending Dec 31, 2022.

Revenue for the year was $689,000 .

The Newyork, Massachusetts (MA)-based company operating in the pharmaceutical preparations sector with 113 employees has total shareholders equity of $46.27 million.

Also read:

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.